Immune cells in the mouse meninges and along brain blood vessels take up amyloid in a daily rhythm that depends on the clock gene Bmal1
Immune cells in the mouse meninges and along brain blood vessels take up amyloid in a daily rhythm that depends on the clock gene Bmal1
On November 17, Immunity published a study by Beth Stevens’s group at Harvard Medical School. The researchers measured gene activity in brain immune cells every six hours. Border-associated macrophages, which reside in the meninges and along brain blood vessels, had the most genes whose activity differed between the start of the day and the start of the night.
A 2018 paper showed that disabling the circadian clock gene Bmal1 in the brain increases amyloid plaque deposition in mouse models of Alzheimer’s disease. The authors of the new study consider the cellular mechanisms behind this link unresolved.
Border-associated macrophages are immune cells that clear substances dissolved in brain fluid by taking them up. Within brain tissue, another cell type, microglia, performs similar clearance functions. Beth Stevens received a MacArthur Fellowship in 2015 for her work showing that microglia engulf excess synapses.
At night, when mice are active, border-associated macrophages expressed genes involved in defense, including pathogen recognition and phagocytosis. At the start of their daytime rest period, expression increased for genes involved in DNA repair and clathrin-mediated endocytosis, the rapid uptake of dissolved molecules into vesicles coated with the protein clathrin.
Amyloid-beta, which forms plaques, accumulates in brain fluid during wakefulness and is cleared more efficiently during sleep. The authors hypothesized that border-associated macrophages along fluid drainage pathways take up amyloid on a daily schedule. They tested this in 5xFAD mice, an amyloid-producing model of Alzheimer’s disease. Before plaques appeared, the amyloid signal inside these cells was almost twice as strong during the day as at night.
To compare cells exposed to the same supply of amyloid, the researchers enzymatically dissociated brain tissue into individual cells for 30 minutes in a solution containing labeled amyloid. Border-associated macrophages took up four times as much amyloid as macrophages that had entered from the blood and 11 times as much as microglia. At the start of the day, they took up almost 30% more than at the start of the night. The authors describe the potential benefit of rapid endocytosis: “The rapid process of clathrin-mediated endocytosis may allow border-associated macrophages to take up fluid-borne substances that are present at brain borders only briefly.”
Using ovalbumin as a test protein, the researchers examined whether the daily difference in uptake arose from light, sleep, or the cells’ own clocks. The difference persisted in complete darkness and after six hours of sleep deprivation, but disappeared when Bmal1 was disabled in border-associated macrophages. Among the genes whose expression rose at the start of the rest period was the gene encoding the CD206 receptor. Cells lacking this receptor took up substantially less amyloid, and loss of one of the two gene copies abolished the daily difference in ovalbumin uptake.
Daily rhythms weaken with age. In mice nearly two years old, amyloid uptake was approximately 30% lower than in young mice, and the daily difference in ovalbumin uptake fell from approximately 30% to 10%.
The researchers disabled Bmal1 predominantly in border-associated macrophages in 5xFAD mice. By four months of age, these mice had more plaques in the meninges and around blood vessels than control mice. Levels of the protein from which amyloid is produced were the same as in controls. Before plaques appeared, their border-associated macrophages took up less amyloid and had less CD206. The authors suggest that reduced clearance may partly explain the greater plaque burden.
The authors propose that circadian clock disruption during aging or night-shift work may harm the brain in part by causing border-associated macrophages to clear harmful proteins at the wrong time.